Company Data| Company Name | UMN Pharma Inc. |
|---|---|
| Incorporated | April 20, 2004 |
| Paid in Capital | 5,288 million yen |
| Stock Exchange | Tokyo Stock Exchange, MOTHERS |
| Code | 4585 |
| Business contents | Development and manufacture of biopharmaceuticals |
| Chairman & CEO | Masahiro Michishita M.D., Ph.D. |
| Akita Office and Akita Plant |
4-2-3, Gosyonoyumoto, Akita, Akita 010-1415, Japan |
| Yokohama Headquarters | The Landmark Tower Yokohama 26F, 2-2-1 Minato Mirai, Nishi-ku, Yokohama, Kanagawa 220-8126, Japan TEL +81-45-263-9200 FAX +81-45-263-9205 |
| Yokohama Research Center |
610-1, Nippa-cho, Kohoku-ku, Yokohama, Kanagawa 223-0057, Japan |
| Akita Laboratory | Molecular Medicine Laboratory, Bioscience Education and Research Center, Akita University, 1-1-1, Hondo, Akita, Akita 010-8543, Japan |
SubsidiaryUNIGEN Inc. website |
4-2-3, Gosyonoyumoto, Akita, Akita 010-1415, Japan |
|---|---|
| Gifu Plant | 11 Aza Kamikasugo, Miyaji, Ikeda-cho, Ibi-gun, Gifu 503-2406, Japan |
